Suppr超能文献

哮喘患者气道炎症、网状基底膜增厚与对乙酰甲胆碱支气管高反应性之间的相互关系;一项系统性支气管肺泡灌洗和气道活检分析

Inter-relationships between airway inflammation, reticular basement membrane thickening and bronchial hyper-reactivity to methacholine in asthma; a systematic bronchoalveolar lavage and airway biopsy analysis.

作者信息

Ward C, Reid D W, Orsida B E, Feltis B, Ryan V A, Johns D P, Walters E H

机构信息

Applied Immunobiology and Transplantation Research Group, The Freeman Hospital and University of Newcastle upon Tyne, UK.

出版信息

Clin Exp Allergy. 2005 Dec;35(12):1565-71. doi: 10.1111/j.1365-2222.2005.02365.x.

Abstract

BACKGROUND

Asthma is accepted as a disease characterized by airway inflammation, with evidence that airway structural changes, or 'remodelling' occurs. There are few studies relating airway physiology, inflammation and remodelling, however. We have carried out a study of inter-relationships between airway inflammation, airway remodelling, reticular basement membrane (RBM) thickening, and bronchial hyper-reactivity (BHR), before and after high-dose inhaled corticosteroid (fluticasone propionate 750 microg b.d.), in a group of relatively mild but symptomatic, steroid naïve asthma patients.

METHODS

Double-blind, randomized, placebo-controlled, parallel group study of inhaled corticosteroid (ICS) in 35 asthmatics, with bronchoalveolar lavage (BAL) and airway endobronchial biopsy (EBB) for inflammatory cell profiles and EBB for airway remodelling carried out at baseline, 3 and 12 months.

RESULTS

At baseline RBM thickening was related to BAL mast cells and EBB eosinophil counts. In turn baseline log EBB EG2 eosinophil count, log%BAL epithelial cells and log RBM thickness explained 55% of the variability in BHR.

CONCLUSION

We provide new information that airway inflammation, remodelling, and BHR in asthma are inter-related and improved by ICS therapy. Our data potentially support the need for early and long-term intervention with ICS even in relatively mild asthmatics, and the need to further assess the potential merit of longitudinal BHR testing in management of some patients, as this may reflect both airway inflammation and remodelling.

摘要

背景

哮喘被认为是一种以气道炎症为特征的疾病,有证据表明会出现气道结构改变或“重塑”。然而,很少有研究涉及气道生理学、炎症和重塑之间的关系。我们对一组相对轻度但有症状、未使用过类固醇的哮喘患者在高剂量吸入皮质类固醇(丙酸氟替卡松,每日两次,每次750微克)治疗前后的气道炎症、气道重塑、网状基底膜(RBM)增厚和支气管高反应性(BHR)之间的相互关系进行了研究。

方法

对35名哮喘患者进行吸入皮质类固醇(ICS)的双盲、随机、安慰剂对照、平行组研究,在基线、3个月和12个月时进行支气管肺泡灌洗(BAL)和气道支气管内活检(EBB)以获取炎症细胞谱,并进行EBB以评估气道重塑。

结果

在基线时,RBM增厚与BAL肥大细胞和EBB嗜酸性粒细胞计数有关。反过来,基线时EBB中EG2嗜酸性粒细胞计数的对数、BAL上皮细胞百分比的对数和RBM厚度的对数解释了BHR变异性的55%。

结论

我们提供了新的信息,即哮喘中的气道炎症、重塑和BHR相互关联,并且ICS治疗可使其得到改善。我们的数据可能支持即使在相对轻度的哮喘患者中也需要早期和长期使用ICS进行干预,以及进一步评估在某些患者管理中进行纵向BHR检测的潜在价值,因为这可能反映气道炎症和重塑。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验